Dombivli Life-Science Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 07-12-2024
- Paid Up Capital ₹ 0.15 M
as on 07-12-2024
- Company Age 2 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.59 Cr
as on 07-12-2024
About Dombivli Life-Science
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹3.59 Cr.
Deepak Patkar, Girish Yevankar, and Raunaklaxmi Shirsath serve as directors at the Company.
- CIN/LLPIN
U85100MH2022PTC374760
- Company No.
374760
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jan 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dombivli Life-Science?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raunaklaxmi Shirsath  | Director | 12-Jan-2022 | Current |
| Deepak Patkar | Director | 12-Jan-2022 | Current |
| Girish Yevankar | Director | 12-Jan-2022 | Current |
Financial Performance of Dombivli Life-Science.
Dombivli Life-Science Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dombivli Life-Science?
Unlock access to Dombivli Life-Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Radiology Events Education Fest Associat Es LlpActive 6 years 7 months
Deepak Patkar is a mutual person
- Shivakshar Imaging Centre LlpActive 3 years 1 month
Deepak Patkar and Girish Yevankar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 31 May 2022 | ₹3.59 Cr | Open |
How Many Employees Work at Dombivli Life-Science?
Dombivli Life-Science has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dombivli Life-Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dombivli Life-Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
